The global compression stockings market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2023-2028.
Compression stockings apply gentle pressure over the ankles and calves to improve blood flow, inhibit the formation of blood clots, and reduce pain. As a result, they help prevent edema, lymphedema, phlebitis, spider and varicose veins, and deep vein thrombosis (DVT). They also aid in improving lower extremity symptoms associated with venous insufficiency during pregnancy. Besides this, they can be used as a non-pharmacological treatment option for individuals with orthostatic hypotension (OH). Some of the commonly used compression stockings include graduated compression stockings (GCS), anti-embolism stockings, and non-medical support hosiery.
Compression Stockings Market Trends:
Chronic venous disease (CVD) is widespread, underdiagnosed, and can progress to chronic venous insufficiency (CVI) and venous leg ulcers (VLU), which require extensive treatment and hospitalization. This, coupled with the rising prevalence of obesity on account of sedentary lifestyles, represents one of the key factors bolstering the growth of the market. Besides this, compression therapy using compression stockings assists in the treatment of VLU as it results in ulcer healing, reduction of pain, and prevention of recurrence. It also helps narrow veins, restore valve competence, minimize ambulatory venous pressure, and reduce venous reflux (VR). In addition, it aids in decreasing inflammatory cytokines and lowering capillary fluid leakage, thereby alleviating limb edema. Moreover, leading players are increasingly focusing on aggressive promotional activities for advertising compression stockings to runners, triathletes, and other endurance athletes. These stockings enhance blood circulation during physical activity, boost athletic performance, and enable rapid recovery. This, along with the burgeoning sports industry, is augmenting the overall sales and profitability. Furthermore, the increasing geriatric population around the world is projected to fuel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global compression stockings market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, demography and distribution channel.
Breakup by Product Type:
Breakup by Demography:
Breakup by Distribution Channel:
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 2XU Pty Ltd., Bauerfeind AG, Belsana, Creswell Sock Mills, DJO LLC (Enovis Corporation), Gloria Med Spa, Manifattura Cizeta s.r.l., medi GmbH & Co. KG, Sigvaris AG (Sigvaris Management AG), Spanx Inc., Thuasne and Triumph Home Health Supplies.
|Base Year of the Analysis
||Product Type, Demography, Distribution Channel, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||2XU Pty Ltd., Bauerfeind AG, Belsana, Creswell Sock Mills, DJO LLC (Enovis Corporation), Gloria Med Spa, Manifattura Cizeta s.r.l., medi GmbH & Co. KG, Sigvaris AG (Sigvaris Management AG), Spanx Inc., Thuasne and Triumph Home Health Supplies
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)